Seniors Are Experiencing Record-High RSV Cases

The video discusses the rise in RSV cases, particularly among the elderly, due to weakened immune systems and reduced precautions post-pandemic. It highlights the health risks posed by RSV, flu, and COVID-19, and the ongoing development of RSV vaccines by companies like Pfizer and Moderna. The discussion emphasizes the vulnerability of older adults, including those in nursing facilities, and the importance of protecting both the young and the elderly.

What are the expected timelines for the availability of RSV vaccines for seniors?

Why is it important to consider the health of individuals aged 60-65 in the context of RSV?